NCT06907121View on ClinicalTrials.gov

Investigation of Growth Hormone and Platelet-Rich Plasma on Joint Health

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
Arthritis AnkleArthritis Knee
Interventions
DRUG

Intra-Articular Injection of Growth Hormone and Platelet-Rich Plasma

Intervention will be an intra-articular injection of 10 units of HGH and 10 mL PRP conjunct. Three total injections/placements of HGH spaced 7 to 16 days apart on either the effected ankle or knee joint guided by ultrasound.

Trial Locations (1)

2011

Dr Gordon Slater: Orthopaedic Surgeon, Potts Point

All Listed Sponsors
collaborator

University of Technology, Sydney

OTHER

lead

Integrant Pty Ltd

INDUSTRY

NCT06907121 - Investigation of Growth Hormone and Platelet-Rich Plasma on Joint Health | Biotech Hunter | Biotech Hunter